| 1 |
Xiong ZU, Dan C, Guang RX. Extracellular matrix remodeling in hepa tocellular carcinoma: effects of soil on seed? Medical Hypothesis, 2006, 66(6): 1115-1120.
|
| 2 |
Mittelbronn M, Roser F, Tatagiba M, et al. Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas Schittenhelm. Europathol Appl Neurobiol, 2006, 32(5): 525-531.
|
| 3 |
Delektorskaya VV, Golovkov DA, Kushlinskii NE. Clinical significance of levels of molecular biological markers in zones of invasive front-line of colorectal cancer. Bull Exp Biol Med, 2008, 146(5): 616-619.
|
| 4 |
Ohlund D, Lundin C, Ardnor B, et al. Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer. Br J Cancer, 2009, 101(1): 91-97.
|
| 5 |
Chung IS, Son YI, Ko YJ, et al. Peritumor injections of purified tumstatin delay tumor growth and lymphatic metastasis in an orthotopic oral squamous cell carcinoma model. Oral Oncol, 2008, 44(12):1118-1126.
|
| 6 |
Santos-García A, Abad-Hernández MM, Fonseca-Sánchez E. E-cadherin, laminin and collagen IV expression in the evolution from dysplasia to oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal, 2006, 11(2): E100-105.
|
| 7 |
Jha RK, Ma Q, Chen S, et al. Relationship of fibronectin and CD44v6 expression with invasive growth and metastasis of liver cancer. Cancer Invest, 2009, 27(3): 324-328.
|
| 8 |
Ding J, Li D, Wang X, et al. Fibronectin promotes invasiveness and focal adhesion kinase tyrosine phosphorylation of human colon cancer cell. Hepatogastroenterology, 2008, 55(88): 2072-2076.
|
| 9 |
Zhao Y, Min C, Vora SR, et al. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J Biol Chem, 2009, 284(3): 1385-1393.
|
| 10 |
Slevin M, Krupinski J, Gaffney J, et al. Hyaluronan-mediated angiogenesis in vascular disease: Uncovering RHAMM and CD44 receptor signaling pathways. MatrixBiol, 2007, 26(1): 58-68.
|
| 11 |
Bharadwaj AG, Kovar JL, Loughman E, et al. Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and Processing. Am J Pathol, 2009, 174(3): 1027-1036.
|
| 12 |
Han Z, Lin GJ, Chi FL, et al. The relationship between the extracellular matrix and the angiogenesis and metastasis of laryngeal carcinoma. ORL J Otorhinolaryngol Relat Spec, 2008, 70(6): 352-358.
|
| 13 |
Narita K, Staub J, Chien J, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Research, 2006, 66(12): 6025-6032.
|
| 14 |
Whipple CA, Lander AD, Korc M. Discovery of a novel molecule that regulates tumor growth and metastasis. ScientificWorldJournal, 2008, 8: 1250-1253.
|
| 15 |
Jodele S, Blavier L, Janet M, et al. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression. Cancer Metastasis Rev, 2006, 25(1): 35-43.
|
| 16 |
Ambalavanan N, Nicola T, Li P, et al. Role of Matrix Metalloproteinase-2 in Newborn Mouse Lungs under Hypoxic Conditions. Pediatr Res, 2008, 63(1): 26-32.
|
| 17 |
Kenny HA, Lengyel E. MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle, 2009, 8(5): 683-688.
|
| 18 |
Mitsiades N, Yu WH, Poulaki V, et al. Matrix Metalloproteinase-7-mediated Cleavage of Fas Ligand Protects Tumor Cells from Chemotherapeutic Drug Cytotoxicity. Cancer Res, 2001, 61(2): 577-581.
|
| 19 |
Wang L, Madigan MC, Chen H, et al. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients. Gynecol Oncol, 2009, 114(2): 265-272.
|
| 20 |
JoM, Takimoto S, Montel V, et al. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. Am J Pathol, 2009, 175(1): 190-200.
|
| 21 |
Zhou H, Tang Y, Liang X, et al. RNAi targeting urokinase-type plasminogen activator receptor inhibits metastasis and progression of oral squamous cell carcinoma in vivo. Int J Cancer, 2009, 125(2): 453-462.
|
| 22 |
Devetzi M, Scorilas A, Tsiambas E, et al. Cathepsin B protein levels in endometrial cancer: Potential value as a tumour biomarker. Gynecol Oncol, 2009, 112(3): 531-536.
|
| 23 |
XuX, Yuan G, Liu W, et al. Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance. Exp Oncol, 2009, 31(2): 102-105.
|
| 24 |
Hu L, Roth JM, Brooks P, et al. Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res, 2008, 68(12): 4666-4673.
|
| 25 |
Chen G, Dang YW, Luo DZ, et al. Expression of heparanase in hepatocellular carcinoma has prognostic significance: a tissue microarray study. Oncology Res, 2008, 17(4): 183-189.
|
| 26 |
Roy M, Marchetti D. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis. J Cell Biochem, 2009, 106(2): 200-209.
|